Studies have shown that using low-dose CT scans to screen for lung cancer can detect cancer early and save lives. Yet, adoption of CT scanning in the United States has been low, with only an estimated 3 to 5 percent of those eligible for screening actually receiving scans.

Abraham Chachoua, MD, the Jay and Isabel Fine Professor of Oncology in the Department of Medicine and associate director of cancer services at NYU Langone Health’s Perlmutter Cancer Center, talks with OncLive On Air about the cancer center’s new Lung Cancer Screening Program, how it is implemented using electronic medical records to identify eligible people, and the financial implications of screening.

“If an institution does not have a lung cancer screening program, they should. It is actually standard of care,” says Dr. Chachoua, who is also director of Perlmutter Cancer Center’s Lung Cancer Center. “I would urge people to set it up and to set it up in the way that it works in their system and just get it done because it does save lives.”

Listen to Dr. Chachoua’s entire interview with OncLive On Air.